Inogen (INGN) Liabilities and Shareholders Equity (2013 - 2026)

Inogen (INGN) has 14 years of Liabilities and Shareholders Equity data on file, last reported at $285.9 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $285.9 million, down 7.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 1.32% YoY), and the FY2025 annual result was $298.6 million, up 0.82% from the prior year.
• Liabilities and Shareholders Equity eased to $285.9 million in Q1 2026 per INGN's latest filing, from $298.6 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $474.6 million in Q1 2022 and troughed at $285.9 million in Q1 2026.
• A 5-year average of $352.2 million and a median of $315.6 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2023 and 2025: Liabilities and Shareholders Equity decreased 26.81% in 2023, then gained 1.01% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $405.0 million in 2022, then retreated by 19.47% to $326.2 million in 2023, then slipped by 9.2% to $296.2 million in 2024, then advanced by 0.82% to $298.6 million in 2025, then decreased by 4.25% to $285.9 million in 2026.
• Business Quant data shows INGN's Liabilities and Shareholders Equity at $285.9 million in Q1 2026, $298.6 million in Q4 2025, and $307.0 million in Q3 2025.